Publications

Original Research & Reviews (84)

  1. Tembo J, Simulundu E, Changula K, Handley D, Gilbert M, Chilufya M, Asogun D, Ansumana R, Kapata N, Ntoumi F, Ippolito G, Zumla A, Bates M. Recent advances in the development and evaluation of molecular diagnostics for Ebola virus disease. Expert Rev Mol Diagn. 2019 Apr;19(4):325-340.
  2. Mwananyanda L, Pierre C, Mwansa J, Cowden C, Localio AR, Kapasa ML, Machona S, Musyani CL, Chilufya MM, Munanjala G, Lyondo A, Bates MA, Coffin SE, Hamer DH. Preventing Bloodstream Infections and Death in Zambian Neonates: Impact of a Low-cost Infection Control Bundle. Clin Infect Dis. 2018 Dec 28.
  3. Petersen E, Abubakar I, Ihekweazu C, Heymann D, Ntoumi F, Blumberg L, Asogun D, Mukonka V, Lule SA, Bates M, Honeyborne I, Mfinanga S, Mwaba P, Dar O, Vairo F, Mukhtar M, Kock R, McHugh TD, Ippolito G, Zumla A. Monkeypox – Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era. Int J Infect Dis. 2019 Jan;78:78-84.
  4. Ghoma Linguissi LS, Lucaccioni V, Bates M, Zumla A, Ntoumi F. Achieving sustainable development goals for HIV/AIDS in the Republic of the Congo – Progress, obstacles and challenges in HIV/AIDS health services. Int J Infect Dis. 2018 Dec;77:107-112.
  5. Tembo J, Chandwe K, Kabwe M, Chilufya M, Ciccone O, Mpabalwani E, Ablashi D, Zumla A, Chen T, Bates M. Children infected by human herpesvirus 6B with febrile seizures are more likely to develop febrile status epilepticus: A case-control study in a referral hospital in Zambia. J Med Virol. 2018 Nov;90(11):1757-1764.
  6. Walzl G, McNerney R, du Plessis N, Bates M, McHugh TD, Chegou NN, Zumla A. Tuberculosis: advances and challenges in development of new diagnostics and biomarkers. Lancet Infect Dis. 2018 Mar 23.
  7. Tiberi S, Petersen E, Maeurer M, Ntoumi F, Yeboa-Manu D, Mwaba P, Vilaplana C, Dar O, Bates M, Corrah T, Rao M, Kapata N, Azhar EI, Memish ZA, Mfinanga S, Aseffa A, Ippolito G, Migliori GB, Zumla A. Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 – “Wanted: Leaders for a TB-Free World. You can make history. End TB”. Int J Infect Dis. 2018 Mar 22.
  8. Tembo J, Moraleda C, Rojo P, Zumla A, Bates M. Urgent need for multi-site controlled trials for CMV pneumonia treatment in African children. Int J Tuberc Lung Dis. 2018 Apr 1;22(4):469-470.
  9. Malisheni M, Khaiboullina SF, Rizvanov AA, Takah N, Murewanhema G, Bates M. Clinical Efficacy, Safety, and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine (CYD-TDV) in Children: A Systematic Review with Meta-analysis. Front Immunol. 2017 Aug 4;8:863.
  10. Kapata N, Grobusch MP, Chongwe G, Chanda-Kapata P, Ngosa W, Tembo M, Musonda S, Katemangwe P, Bates M, Mwaba P, Zumla A, Cobelens F. Outcomes of multidrug-resistant tuberculosis in Zambia: a cohort analysis. Infection. 2017 Aug 4. doi: 10.1007/s15010-017-1054-8. [Epub ahead of print]
  11. Zumla A, Ippolito G, McCloskey B, Bates M, Ansumana R, Heymann D, Kock R, Ntoumi F. Enhancing preparedness for tackling new epidemic threats. Lancet Respir Med. 2017 Aug;5(8):606-608. doi: 10.1016/S2213-2600(17)30189-3. Epub 2017 May 18. No abstract available.
  12. Linguissi LS, Gwom LC, Nkenfou CN, Bates M, Petersen E, Zumla A, Ntoumi F. Health systems in the Republic of Congo: challenges and opportunities for implementing tuberculosis and HIV collaborative service, research, and training activities. Int J Infect Dis. 2017 Mar;56:62-67. doi: 10.1016/j.ijid.2016.10.012. Epub 2016 Oct 27.
  13. Polepole P, Kabwe M, Kasonde M, Tembo J, Shibemba A, O’Grady J, Kapata N, Zumla A, Bates M. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues. Int J Mycobacteriol. 2017 Jan-Mar;6(1):87-93. doi: 10.4103/2212-5531.201892.
  14. Girardi E, Sañé Schepisi M, Goletti D, Bates M, Mwaba P, Yeboah-Manu D, Ntoumi F, Palmieri F, Maeurer M, Zumla A, Ippolito G. The global dynamics of diabetes and tuberculosis: the impact of migration and policy implications. Int J Infect Dis. 2017 Mar;56:45-53. doi: 10.1016/j.ijid.2017.01.018. Epub 2017 Jan 30. Review.
  15. Bates M, Polepole P, Kapata N, Loose M, O’Grady J. Application of highly portable MinION nanopore sequencing technology for the monitoring of nosocomial tuberculosis infection. Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S24. doi: 10.1016/j.ijmyco.2016.10.035. Epub 2016 Nov 23.
  16. Zumla A, Otchere ID, Mensah GI, Asante-Poku A, Gehre F, Maeurer M, Bates M, Mwaba P, Ntoumi F, Yeboah-Manu D. Learning from epidemiological, clinical, and immunological studies on Mycobacterium africanum for improving current understanding of host-pathogen interactions, and for the development and evaluation of diagnostics, host-directed therapies, and vaccines for tuberculosis. Int J Infect Dis. 2017 Mar;56:126-129. doi: 10.1016/j.ijid.2016.12.003. Epub 2016 Dec 12. Review.
  17. Simulundu E, Mweene AS, Changula K, Monze M, Chizema E, Mwaba P, Takada A, Ippolito G, Kasolo F, Zumla A, Bates M. Lujo viral hemorrhagic fever: considering diagnostic capacity and preparedness in the wake of recent Ebola and Zika virus outbreaks. Rev Med Virol. 2016 Sep 5.
  18. Bates M, Brantsaeter A. Human cytomegalovirus (CMV) infections in sub-Saharan Africa – a neglected but important pathogen. J Virol Erad 2016 Jul 1;2(3):136-42
  19. Bates M, Shibemba A, Mudenda V, Chimoga C, Tembo J, Kabwe M, Chilufya M, Hoelscher M, Maeurer M, Sinyangwe S, Mwaba P, Kapata N, Zumla A. Burden of respiratory tract infections at post mortem in Zambian children. BMC Med. 2016 Jul 1;14(1):99. IF7.2
  20. Zumla A, Dar O, Cotton M, Azhar E.I, Ntoumi F, Kaleebu P, Macete E, Bates M, Mwaba P, Khan M, Maeurer M, Ippolito G, Petersen E. Taking forward a ‘ONE HEALTH’ approach for turning the tide against The Middle East Respiratory Syndrome Coronavirus and other zoonotic pathogens with epidemic potential. Int J Infect Dis In press 2016. IF1.9
  21. Ippolito G, Lanini S, Brouqui P, Di Caro A, Vairo F, Fusco FM, Krishna S, Capobianchi MR, Kyobe-Bosa H, Puro V, Wölfel R, Avsic-Zupanc T, Ioannidis JP, Portella G, Kremsner P, Dar O, Bates M, Zumla A. Non-randomised Ebola trials-lessons for optimal outbreak research. Lancet Infect Dis. 2016 Apr;16(4):407-8. IF22.4
  22. Kabwe M, Tembo J, Chilukutu L, Chilufya M, Ngulube F, Lukwesa C, Kapasa M, Enne V, Wexner H, Mwananyanda L, Hamer DH, Sinyangwe S, Ahmed Y, Klein N, Maeurer M, Zumla A, Bates M. Etiology, Antibiotic Resistance and Risk Factors for Neonatal Sepsis in a Large Referral Center in Zambia. Pediatr Infect Dis J. 2016 Mar 30. IF2.7
  23. Ntoumi F, Kaleebu P, Macete E, Mfinanga S, Chakaya J, Yeboah-Manu D, Bates M, Mwaba P, Maeurer M, Petersen E, Zumla A. Taking forward the World TB Day 2016 theme ‘Unite to End Tuberculosis’ for the WHO Africa Region. Int J Infect Dis. 2016 Mar 8. IF1.9
  24. Zumla A, Goodfellow I, Kasolo F, Ntoumi F, Buchy P, Bates M, Azhar EI, Cotten M, Petersen E. Zika virus outbreak and the case for building effective and sustainable rapid diagnostics laboratory capacity globally. Int J Infect Dis. 2016 Mar 4;45:92-94. IF1.9
  25. Zumla A, Saeed AB, Alotaibi B, Yezli S, Dar O, Bieh K, Bates M, Tayeb T, Mwaba P, Shafi S, McCloskey B, Petersen E, Azhar EI. Tuberculosis and Mass Gatherings-opportunities for defining burden, transmission risk, and optimal surveillance, prevention and control measures at the annual Hajj pilgrimage. Int J Infect Dis. 2016 Feb 9. IF1.9
  26. Petersen E, Wilson ME, Touch S, McCloskey B, Mwaba P, Bates M, Dar O, Mattes F, Kidd M, Ippolito G, Azhar EI, Zumla A. Rapid Spread of Zika Virus in The Americas – Implications for Public Health Preparedness for Mass Gatherings at the 2016 Brazil Olympic Games. Int J Infect Dis. 2016 Feb 4. IF1.9
  27. Bates M, Zumla A. The development, evaluation and performance of molecular diagnostics for detection of Mycobacterium tuberculosis. Expert Rev Mol Diagn. 2016 Jan 6. IF3.3
  28. Bates M, Zumla A. Rapid infectious diseases diagnostics using Smartphones. Annals of Translational Medicine. 2015 Sep;3(15):215.
  29. Schito M, Migliori GB, Fletcher HA, McNerney R, Centis R, D’Ambrosio L, Bates M, Kibiki G, Kapata N, Corrah T, Bomanji J, Vilaplana C, Johnson D, Mwaba P, Maeurer M, Zumla A. Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines. Clin Infect Dis. 2015 Oct 15;61Suppl 3:S102-18. IF8.9
  30. Zumla A, Bates M, Maeurer M. Corticosteroid therapy for pneumonia. Lancet. 2015 Sep 5;386(9997):955. IF45.2
  31. Ippolito G, Lanini S, Brouqui P, Di Caro A, Vairo F, Abdulla S, Fusco FM, Krishna S, Capobianchi MR, Kyobe-Bosa H, Lewis DJ, Puro V, Wolfel R, Avsic-Zupanc T, Dar O, Mwaba P, Bates M, Heymann D, Zumla A. Ebola: missed opportunities for Europe-Africa research. Lancet Infect Dis. 2015 Jul 28. IF22.4
  32. Zumla A, Maeurer M; Host-Directed Therapies Network (HDT-NET) Consortium. Host-Directed Therapies for tackling Multi-Drug Resistant TB – learning from the Pasteur-Bechamp debates. Clin Infect Dis. 2015 Jul 28. IF8.9
  33. Zumla A, Chakaya J, Hoelscher M, Ntoumi F, Rustomjee R, Vilaplana C, Yeboah-Manu D, Rasolof V, Munderi P, Singh N, Aklillu E, Padayatchi N, Macete E, Kapata N, Mulenga M, Kibiki G, Mfinanga S, Nyirenda T, Maboko L, Garcia-Basteiro A, Rakotosamimanana N, Bates M, Mwaba P, Reither K, Gagneux S, Edwards S, Mfinanga E, Abdulla S, Cardona PJ, Russell JB, Gant V, Noursadeghi M, Elkington P, Bonnet M, Menendez C, Dieye TN, Diarra B, Maiga A, Aseffa A, Parida S, Wejse C, Petersen E, Kaleebu P, Oliver M, Craig G, Corrah T, Tientcheu L, Antonio M, Rao M, McHugh TD, Sheikh A, Ippolito G, Ramjee G, Kaufmann SH, Churchyard G, Steyn A, Grobusch M, Sanne I, Martinson N, Madansein R, Wilkinson RJ, Mayosi B, Schito M, Wallis RS, Maeurer M. Towards host-directed therapies for tuberculosis. Nat Rev Drug Discov. 2015 Jul 17.
  34. Zumla A, Rustomjee R, Ntoumi F, Mwaba P, Bates M, Maeurer M, Hui DS, Petersen E. Middle East Respiratory Syndrome – need for increased vigilance and watchful surveillance for MERS-CoV in sub-Saharan African Africa. Int J Infect Dis. 2015 Jul 2. IF1.9
  35. Kroidl I, Clowes P, Reither K, Mtafya B, Rojas-Ponce G, Ntinginya EN, Kalomo M, Minja LT, Kowuor D, Saathoff E, Kroidl A, Heinrich N, Maboko L, Bates M, O’Grady J, Zumla A, Hoelscher M, Rachow A. Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania. Eur Respir J. 2015 Jun 25. IF7.6
  36. von Delft A, Dramowski A, Khosa C, Kotze K, Lederer P, Mosidi T, Peters J.A, Smith J, van der Westhuizen H, von Delft D, Willems B, Bates M, Craig G, Maeurer M, Marais B, Mwaba P, Nunes E, Nyirenda T, Oliver M, Zumla A. Why health care workers are sick of TB. Int J Infect Dis, 2015 Mar;32:147-51 IF1.9
  37. Bates M, Ahmed Y, Kapata N, Maeurer M, Mwaba P, Zumla A. Perspectives on Tuberculosis in Pregnancy. Int J Infect Dis, 2015 Mar 32:124-7 IF1.9
  38. Axelsson-Robertson R, Rao M, Loxton AG, Walzl G, Bates M, Zumla A, Maeurer M. Frequency of Mycobacterium tuberculosis-specific CD8+ T-cells in the course of anti-tuberculosis treatment. Int J Infect Dis. 2015 Mar;32:23-9. IF1.9
  39. Zumla A, Chakaya J, Centis R, D’Ambrosio L, Mwaba P, Bates M, Kapata N, Nyirenda T, Chanda D, Mfinanga S, Hoelscher M, Maeurer M, Migliori GB. Tuberculosis treatment and management-an update on treatment regimens, trials, new drugs, and adjunct therapies. Lancet Respir Med. 2015 Mar;3(3):220-34. IF9.6
  40. Bates M, Mudenda V, Shibemba A, Kaluwaji J, Tembo J, Kabwe M, Chimoga C, Chilukutu L, Chilufya M, Kapata N, Hoelscher M, Maeurer M, Mwaba P, Zumla A. Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: a prospective descriptive autopsy study. Lancet Infect Dis. 2015 Mar 9 IF22.4
  41. Zumla A, Bates M, Mwaba P. The neglected global burden of tuberculosis in pregnancy. Lancet Glob Health. 2014 Dec;2(12); IF10
  42. Bates M, Kabwe M, Zumla A. Neonatal sepsis and antibiotic resistance in developing countries. Paed Infect Dis J. Oct; 33(10):1097. IF2.7
  43. Tembo J, Kabwe M, Chilukutu L, Chilufya M, Mwaanza N, Chabala C, Zumla A, Bates M. Prevalence and risk factors for betaherpesvirus DNAemia in infants aged between 3 weeks and 2 years of age, admitted to a large referral hospital in sub-Saharan Africa. Clin Infect Dis. 2015 Feb 1;60(3):423-31. IF8.9
  44. Zumla A, Bates M, Maeurer M. Pregnancy and infection. N Engl J Med. 2014 Sep 11; IF55.9
  45. Zumla A, Memish ZA, Maeurer M, Bates M, Mwaba P, Al-Tawfiq JA, Denning DW, Hayden FG, Hui DS. Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options. Lancet Infect Dis. 2014 Sep 1 IF22.4
  46. Zumla A, Al-Tawfiq JA, Enne VI, Kidd M, Drosten C, Breuer J, Muller MA, Hui D, Maeurer M, Bates M, Mwaba P, Al-Hakeem R, Gray G, Gautret P, Al-Rabeeah AA, Memish ZA, Gant V. Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections-needs, advances, and future prospects. Lancet Infect Dis. 2014 Sep 1 IF22.4
  47. Zumla A, Mwaba P, Bates M, Al-Tawfiq JA, Maeurer M, Memish ZA. The Hajj pilgrimage and surveillance for Middle East Respiratory syndrome coronavirus in pilgrims from African countries. Trop Med Int Health. 2014 Jul;19(7):838-40. IF2.3
  48. Bates M, Tembo J, Zumla A. Congenital cytomegalovirus infections in sub-Saharan Africa – a neglected and growing problem. Trop Med Int Health. 2014 Apr 10. IF2.3
  49. Zumla A, Gant V, Bates M, Mwaba P, Maeurer M, Memish ZA. Rapid diagnostics urgently needed for killer infections. Lancet Respir Med. 2013 Jun;1(4):284-5. IF9.6
  50. Janssen S, Huson MA, Bélard S, Stolp S, Kapata N, Bates M, van Vugt M, Grobusch MP. TB and HIV in the Central African region: current knowledge and knowledge gaps. Infection. 2013 Dec 6. IF2.6
  51. Mwaanza N, Chilukutu L, Tembo J, Kabwe M, Musonda K, Kapasa M, Chabala C, Sinyangwe S, Mwaba P, Zumla A, Bates M. High Rates of Congenital Cytomegalovirus Infection Linked With Maternal HIV Infection Among Neonatal Admissions at a Large Referral Center in Sub-Saharan Africa. Clin Infect Dis. 2014 Mar;58(5):728-35. IF8.9
  52. Kapata N, Chanda-Kapata P, Bates M, Mwaba P, Cobelens F, Grobusch MP, Zumla A. Multidrug-resistant TB in Zambia: review of national data from 2000 to 2011. Trop Med Int Health. 2013 Sep 11. IF2.3
  53. Bates M, Ahmed Y, Chilukutu L, Tembo J, Cheelo B, Sinyangwe S, Kapata N, Maeurer M, O’Grady J, Mwaba P, Zumla A. Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia. Trop Med Int Health. 2013 Sep;18(9):1134-40. IF2.3
  54. Marais BJ, Lönnroth K, Lawn SD, Migliori GB, Mwaba P, Glaziou P, Bates M, Colagiuri R, Zijenah L, Swaminathan S, Memish ZA, Pletschette M, Hoelscher M, Abubakar I, Hasan R, Zafar A, Pantaleo G, Craig G, Kim P, Maeurer M, Schito M, Zumla A. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis. 2013 May;13(5):436-48. IF22.4
  55. Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, Masham S, Adetifa I, Ford N, Cox H, Lawn SD, Marais BJ, McHugh TD, Mwaba P, Bates M, Lipman M, Zijenah L, Logan S, McNerney R, Zumla A, Sarda K, Nahid P, Hoelscher M, Pletschette M, Memish ZA, Kim P, Hafner R, Cole S, Migliori GB, Maeurer M, Schito M, Zumla A. Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis. 2013 Jun;13(6):529-39. IF22.4
  56. Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, Marais BJ, Cuevas LE, McHugh TD, Zijenah L, Kapata N, Abubakar I, McNerney R, Hoelscher M, Memish ZA, Migliori GB, Kim P, Maeurer M, Schito M, Zumla A. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis. 2013 Apr;13(4):349-61. IF22.4
  57. Sanz-Ramos M, Manno D, Kapambwe M, Ndumba I, Musonda KG, Bates M, Chibumbya J, Siame J, Monze M, Filteau S, Gompels UA; CIGNIS study team. Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure. Vaccine. 2013 Apr 12;31(16):2042-9. IF3.6
  58. Bates M, Mudenda V, Mwaba P, Zumla A. Deaths due to respiratory tract infections in Africa: a review of autopsy studies. Curr Opin Pulm Med. 2013 May;19(3):229-37. IF2.8
  59. Kapata N, Chanda-Kapata P, O’Grady J, Bates M, Mwaba P, Janssen S, Marais B, Cobelens F, Grobusch M, Zumla A. Trends in childhood tuberculosis in Zambia: a situation analysis. J Trop Pediatr. 2013 Apr;59(2):134-9. IF1.3
  60. Bates M, O’Grady J, Maeurer M, Tembo J, Chilukutu L, Chabala C, Kasonde R, Mulota P, Mzyece J, Chomba M, Mukonda L, Mumba M, Kapata N, Rachow A, Clowes P, Hoelscher M, Mwaba P, Zumla A. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study. Lancet Infect Dis. 2013 Jan;13(1):36-42. IF22.4
  61. Bates M, O’Grady J, Mudenda V, Shibemba A, Zumla A. New global estimates of malaria deaths. Lancet. 2012 Aug 11;380(9841):560-1. IF45.2
  62. Bates M, O’Grady J, Mwaba P, Chilukutu L, Mzyece J, Cheelo B, Chilufya M, Mukonda L, Mumba M, Tembo J, Chomba M, Kapata N, Rachow A, Clowes P, Maeurer M, Hoelscher M, Zumla A. Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients. PLoS One. 2012;7(7):e40774. IF3.2
  63. Kapata N, Chanda-Kapata P, Grobusch MP, O’Grady J, Bates M, Mwaba P, Zumla A. Leprosy trends in Zambia 1991-2009. Trop Med Int Health. 2012 Oct;17(10):1289-93. IF2.3
  64. O’Grady J, Bates M, Chilukutu L, Mzyece J, Cheelo B, Chilufya M, Mukonda L, Mumba M, Tembo J, Chomba M, Kapata N, Maeurer M, Rachow A, Clowes P, Hoelscher M, Mwaba P, Zumla A. Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic. Clin Infect Dis. 2012 Nov;55(9):1171-8. IF8.9
  65. Reddington K, Zumla A, Bates M, van Soolingen D, Niemann S, Barry T, O’Grady J. SeekTB, a two-stage multiplex real-time-PCR-based method for differentiation of the Mycobacterium tuberculosis complex. J Clin Microbiol. 2012 Jul;50(7):2203-6. IF4.0
  66. McNerney R, Maeurer M, Abubakar I, Marais B, McHugh TD, Ford N, Weyer K, Lawn S, Grobusch MP, Memish Z, Squire SB, Pantaleo G, Chakaya J, Casenghi M, Migliori GB, Mwaba P, Zijenah L, Hoelscher M, Cox H, Swaminathan S, Kim PS, Schito M, Harari A, Bates M, Schwank S, O’Grady J, Pletschette M, Ditui L, Atun R, Zumla A. Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis. 2012 May 15;205 Suppl 2:S147-58. IF6.0
  67. Kapata N, Chanda-Kapata P, Grobusch MP, O’Grady J, Schwank S, Bates M, Jansenn S, Mwinga A, Cobelens F, Mwaba P, Zumla A. Scale-up of TB and HIV programme collaborative activities in Zambia – a 10-year review. Trop Med Int Health. 2012 Jun;17(6):760-6. IF2.3
  68. Mudenda V, Lucas S, Shibemba A, O’Grady J, Bates M, Kapata N, Schwank S, Mwaba P, Atun R, Hoelscher M, Maeurer M, Zumla A. Tuberculosis and tuberculosis/HIV/AIDS-associated mortality in Africa: the urgent need to expand and invest in routine and research autopsies. J Infect Dis. 2012 May 15;205 Suppl 2:S340-6. IF6.0
  69. Gompels UA, Larke N, Sanz-Ramos M, Bates M, Musonda K, Manno D, Siame J, Monze M, Filteau S; CIGNIS Study Group. Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia. Clin Infect Dis. 2012 Feb 1;54(3):434-42. IF8.9
  70. O’Grady J, Maeurer M, Atun R, Abubakar I, Mwaba P, Bates M, Kapata N, Ferrara G, Hoelscher M, Zumla A. Tuberculosis in prisons: anatomy of global neglect. Eur Respir J. 2011 Oct;38(4):752-4. IF7.6
  71. Kapata N, Chanda-Kapata P, O’Grady J, Schwank S, Bates M, Mukonka V, Zumla A, Mwaba P. Trends of Zambia’s tuberculosis burden over the past two decades. Trop Med Int Health. 2011 Nov;16(11):1404-9. IF2.3
  72. O’Grady J, Mwaba P, Bates M, Kapata N, Zumla A. Tuberculosis in prisons in sub-Saharan Africa–a potential time bomb. S Afr Med J. 2011 Feb;101(2):107-8. IF1.6
  73. Mwaba P, McNerney R, Grobusch MP, O’Grady J, Bates M, Kapata N, Maeurer M, Zumla A. Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis. Trop Med Int Health. 2011 Jul;16(7):819-27. IF2.3
  74. O’Grady J, Maeurer M, Mwaba P, Kapata N, Bates M, Hoelscher M, Zumla A. New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis. Curr Opin Pulm Med. 2011 May;17(3):134-41. IF2.8
  75. Zumla A, Atun R, Maeurer M, Mwaba P, Ma Z, O’Grady J, Bates M, Dheda K, Hoelscher M, Grange J. Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection. Trop Med Int Health. 2011 Jan;16(1):79-83. IF2.3
  76. O’Grady J, Hoelscher M, Atun R, Bates M, Mwaba P, Kapata N, Ferrara G, Maeurer M, Zumla A. Tuberculosis in prisons in sub-Saharan Africa–the need for improved health services, surveillance and control. Tuberculosis (Edinb). 2011 Mar;91(2):173-8. IF2.7
  77. Filteau S, Baisley K, Chisenga M, Kasonka L, Gibson RS; CIGNIS Study Team. Provision of micronutrient-fortified food from 6 months of age does not permit HIV-exposed uninfected Zambian children to catch up in growth to HIV-unexposed children: a randomized controlled trial. J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):166-75. IF4.6
  78. Chilenje Infant Growth, Nutrition and Infection (CIGNIS) Study Team. Micronutrient fortification to improve growth and health of maternally HIV-unexposed and exposed Zambian infants: a randomised controlled trial. PLoS One. 2010 Jun 17;5(6):e11165. IF3.2
  79. Migliori GB, Dheda K, Centis R, Mwaba P, Bates M, O’Grady J, Hoelscher M, Zumla A. Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa. Trop Med Int Health. 2010 Sep;15(9):1052-66. IF2.3
  80. Mwaba P, Bates M, Green C, Kapata N, Zumla A. Research capacity strengthening in African countries. Lancet. 2010 May 29;375(9729):1874. IF45.2
  81. Bates M, Monze M, Bima H, Kapambwe M, Clark D, Kasolo FC, Gompels UA. Predominant human herpesvirus 6 variant A infant infections in an HIV-1 endemic region of Sub-Saharan Africa. J Med Virol. 2009 May;81(5):779-89. IF2.3
  82. Bates M, Monze M, Bima H, Kapambwe M, Kasolo FC, Gompels UA; CIGNIS study group. High human cytomegalovirus loads and diverse linked variable genotypes in both HIV-1 infected and exposed, but uninfected, children in Africa. Virology. 2008 Dec 5;382(1):28-36. IF3.3
  83. Kasolo FC, Spinks J, Bima H, Bates M, Gompels UA. Diverse genotypes of Kaposi’s sarcoma associated herpesvirus (KSHV) identified in infant blood infections in African childhood-KS and HIV/AIDS endemic region. J Med Virol. 2007 Oct;79(10):1555-61. IF2.3
  84. Zgiby S, Plater AR, Bates MA, Thomson GJ, Berry A. A functional role for a flexible loop containing Glu182 in the class II fructose-1,6-bisphosphate aldolase from Escherichia coli. J Mol Biol. 2002 Jan 11;315(2):131-40. C IF4.3

 

Book Chapters (2)

 

  1. Bates M, Marais B, Zumla A. Tuberculosis co-morbidity with communicable and non-communicable diseases. Perspectives on Tuberculosis, Kaufmann, Rubin and Zumla-Cold Spring Harbour, ISBN  978-1-621820-73-4
  2. Bates M, Musonda K and Zumla A, Human Cytomegalovirus Infections in sub-Saharan Africa Manifestations of cytomegalovirus infection, Manifestations of Cytomegalovirus Infection, Prof. Patricia Price (Ed.), ISBN: 978-953-51-1116-0, InTech, DOI: 10.5772/54907
Viewing Message: 1 of 1.
 Notice

We use cookies to understand how visitors use our website and to improve the user experience. To find out more, see our Cookies Policy.